Adcetris

Mediastinal gray zone lymphoma ( MGZL ) is a rare form of non-Hodgkin lymphoma ( NHL ) with intermediate features...


PD-1 blockade via Pembrolizumab ( Keytruda ) monotherapy has shown antitumor activity in relapsed or refractory classic Hodgkin lymphoma (...



The Chemotherapy Clinical Reference Group ( CRG ) has reviewed drugs and drug indications for inclusion on the National cancer...


The FDA ( Food and Drug Administration ) has approved Adcetris ( Brentuximab vedotin ) for the treatment of patients...


Survival data from two Brentuximab vedotin ( Adcetris ) pivotal Phase 2 clinical trials in relapsed / refractory Hodgkin lymphoma...